Future

In the near term, we are conducting additional studies in North America for our key areas of focus as follows:

  • Topical Toxin (Aesthetics) – an additional study is planned to optimize topical botulinum toxin for aesthetics, including optimizing the Transdermal delivery system and determining the correct dosage of topical toxin.
  • Topical HA (Cosmetic) – additional bench and clinical studies planned to further define and refine the clinical product line.
  • Topical Toxin (Hyperhidrosis) – an additional study is planned to optimize topical botulinum toxin for aesthetics, including optimizing the Transdermal delivery system and determining the correct dosage of topical toxin.
  • Topical BP (acne care) – We anticipate commencing a study for our acne care treatment using our topical BP cream during the fourth quarter of 2010.

In addition, we are pursuing opportunities for partnerships and licensing of our products. We also plan to pursue additional applications and product areas for our technology platform including:

  • Hyper-pigmentation and Melasma
  • Psoriasis
  • Rosacea
  • Topical Anesthesia
  • Onychomycosis
  • Xerosis
  • Cosmetics